Jones David S, Lawlor Michelle S, Woolfson A David
School of Pharmacy, The Queen's University of Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, BT9 7BL, Northern Ireland, United Kingdom.
J Pharm Sci. 2003 May;92(5):995-1007. doi: 10.1002/jps.10357.
This study examined the rheological and mucoadhesive properties of polymeric systems composed of the bioadhesive copolymer poly(methylvinylether-co-maleic anhydride), PMVE/MA and poly(vinylpyrrolidone, PVP) as candidate platforms for improved drug delivery to the oral cavity. Aqueous, neutral formulations were prepared containing PMVE/MA (10 or 15% w/w) and PVP (0-9% w/w). The rheological properties were examined at 20 +/- 0.1 degrees C using both oscillatory rheometry (0.01 to 1.0 Hz at a constant strain of 1.0 x 10(-3) rad) and controlled stress flow rheometry using a Carri-Med CSL(2)-100 rheometer. The mechanical properties were examined using texture profile analysis (15-mm depth of insertion, 9 mm s(-1) rate of insertion, 15 s delay period between the end of the first and beginning of the second compressions). The interaction of the various formulations with mucin was examined using oscillatory rheometry. All formulations exhibited pseudoplastic flow with minimal thixotropy. Increasing the concentration of each polymeric component increased the zero-rate viscosity (calculated using the Cross model), hardness, compressibility, the storage (G') and loss (G") moduli, and decreased the loss tangent. These observations may be due to greater polymeric entanglement between adjacent polymer chains. Specifically, rheological synergy was observed between PMVE/MA and PVP, evidence of complexation between these two polymers. From the relationship between the viscoelastic properties and oscillatory frequency, and the mathematical comparison of steady and oscillatory shear response of formulations using the Cox-Merz equation, it may be concluded that formulations containing 15% w/w PMVE/MA and either 6 or 9% w/w PVP exhibited rheological properties that were consistent with gel behavior. All other formulations exhibited rheological properties that resembled polymeric liquids. Increasing the concentrations of PMVE/MA and PVP significantly increased the interaction with mucin, the rheological synergy between the polymeric formulations and mucin and, in addition, the adhesiveness of the formulations. This is evidence of the muco/bioadhesive properties of the formulations. Conversely, the time of contact between each formulation and mucin did not affect their resultant interaction. In conclusion, this study has uniquely described the rheological and mucoadhesive properties of aqueous systems composed of PMVE/MA and PVP. In particular, the concentrations required for gel formation have been defined and the interaction between these two polymeric components illustrated using rheological methods. Furthermore, the simultaneous analysis of rheological, mechanical, and mucoadhesive data provided an insight into their potential utility as platforms for drug delivery systems for application to the oral cavity.
本研究考察了由生物粘附性共聚物聚(甲基乙烯基醚 - 顺丁烯二酸酐)(PMVE/MA)和聚维酮(PVP)组成的聚合物体系的流变学和粘膜粘附特性,将其作为改善口腔给药的候选平台。制备了含PMVE/MA(10%或15% w/w)和PVP(0 - 9% w/w)的水性中性制剂。在20±0.1℃下,使用振荡流变仪(在1.0×10⁻³弧度的恒定应变下,频率为0.01至1.0 Hz)和使用Carri - Med CSL(2)-100流变仪的控制应力流动流变仪来考察流变学特性。使用质地剖面分析(插入深度15 mm,插入速率9 mm s⁻¹,第一次压缩结束与第二次压缩开始之间延迟15 s)来考察力学性能。使用振荡流变仪考察各种制剂与粘蛋白的相互作用。所有制剂均表现出假塑性流动且触变性极小。增加每种聚合物组分的浓度会增加零剪切速率粘度(使用Cross模型计算)、硬度、压缩性、储能模量(G')和损耗模量(G"),并降低损耗角正切。这些观察结果可能是由于相邻聚合物链之间更大的聚合物缠结。具体而言,在PMVE/MA和PVP之间观察到流变学协同作用,这是这两种聚合物之间络合的证据。从粘弹性性质与振荡频率之间的关系,以及使用Cox - Merz方程对制剂的稳态和振荡剪切响应进行数学比较可以得出结论,含有15% w/w PMVE/MA和6%或9% w/w PVP的制剂表现出与凝胶行为一致的流变学性质。所有其他制剂表现出类似于聚合物液体的流变学性质。增加PMVE/MA和PVP的浓度显著增加了与粘蛋白的相互作用、聚合物制剂与粘蛋白之间的流变学协同作用,此外还增加了制剂的粘附性。这证明了制剂的粘膜/生物粘附特性。相反,每种制剂与粘蛋白的接触时间并未影响它们最终的相互作用。总之,本研究独特地描述了由PMVE/MA和PVP组成的水性体系的流变学和粘膜粘附特性。特别地,已经确定了形成凝胶所需的浓度,并使用流变学方法说明了这两种聚合物组分之间的相互作用。此外,对流变学、力学和粘膜粘附数据的同时分析为它们作为口腔给药系统平台的潜在效用提供了深入了解。